0
0The paper discuss the critical role of menin in the development of blood cells, specifically during megakaryopoiesis. Researchers have identified menin-dependent networks involving genes like MEIS1 and MEF2C as essential drivers of both healthy platelet production and diseased states. In the context of myeloproliferative neoplasms (MPN), these pathways lead to harmful bone marrow fibrosis and excessive cell growth. The text highlights menin inhibitors as a promising therapeutic vulnerability, offering a way to reduce leukocytosis and megakaryocyte hyperplasia. By targeting these specific protein interactions, clinicians may be able to treat aggressive leukemias and related marrow disorders more effectively. This research emphasizes how molecular interference can reverse the pathological features of complex hematologic malignancies.
References:
Wheat J C, Cai S F. Menin in normal and malignant megakaryopoiesis[J]. Cancer Cell, 2026.
